TY - JOUR
T1 - Peroxisome proliferator-activated receptors
T2 - Roles in tumorigenesis and chemoprevention in human cancer
AU - Park, Ben Ho
AU - Breyer, Benjamin
AU - He, Tong Chuan
PY - 2001
Y1 - 2001
N2 - Peroxisome proliferator-activated receptors are nuclear receptors that were isolated for their ability to modulate lipid metabolism. Similar to other members of the nuclear receptor family, peroxisome proliferator-activated receptors bind ligand as heterodimers and exert their effects via transcriptional regulation through their DNA binding domains. During the past decade, it has become clear that peroxisome proliferator-activated receptors also contribute to a variety of different biologic processes, including atherosclerosis, insulin resistance, and more recently, cancer. In this review, we discuss the evidence for the different peroxisome proliferator-activated receptors' roles in tumorigenesis and also their potential application for the treatment and prevention of neoplastic diseases.
AB - Peroxisome proliferator-activated receptors are nuclear receptors that were isolated for their ability to modulate lipid metabolism. Similar to other members of the nuclear receptor family, peroxisome proliferator-activated receptors bind ligand as heterodimers and exert their effects via transcriptional regulation through their DNA binding domains. During the past decade, it has become clear that peroxisome proliferator-activated receptors also contribute to a variety of different biologic processes, including atherosclerosis, insulin resistance, and more recently, cancer. In this review, we discuss the evidence for the different peroxisome proliferator-activated receptors' roles in tumorigenesis and also their potential application for the treatment and prevention of neoplastic diseases.
UR - http://www.scopus.com/inward/record.url?scp=0035167762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035167762&partnerID=8YFLogxK
U2 - 10.1097/00001622-200101000-00015
DO - 10.1097/00001622-200101000-00015
M3 - Article
C2 - 11148691
AN - SCOPUS:0035167762
SN - 1040-8746
VL - 13
SP - 78
EP - 83
JO - Current Opinion in Oncology
JF - Current Opinion in Oncology
IS - 1
ER -